T-Cell Lymphoma Pipeline Insight Analysis Report 2024 - Regulatory Support Drives Fast-Track Development of Novel T Cell Lymphoma Drugs from Eisai, Takeda, and Rhizen Pharmaceuticals Dublin, Nov. 06, 2024 (GLOBE NEWSWIRE) -- The "T-Cell Lymphoma Pipeline Insight Analysis Report" drug pipelines has been added to ResearchAndMarkets.com's offering.T-Cell lymphoma is a type of...

BREYANZI (Lisocabtagene Maraleucel) Drug Insight and Market Forecasts, 2019-2032: An Investigational CAR-T-cell Therapy Designed to Target CD19 - Focus on 7 Major Markets Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "BREYANZI Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides a detailed...

Global Lymphoma Therapeutics Market Report 2023: Sector is Expected to Reach $24.9 Billion by 2029 at a CAGR of 7.8% Dublin, June 06, 2023 (GLOBE NEWSWIRE) -- The "Global Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration...

CAR T-cell Therapy Market Riding on the Wave of Growth and will Grow at a CAGR of 30.6% to 2031 | TMR Study Wilmington, Delaware, United States, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – The solutions in the global CAR T-cell therapy market are increasingly being hailed as...